Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
about
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisFluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosisConsiderations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosisOptimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
P2860
Q24188313-588E8C58-B30A-42A6-86A3-7B02C7857A91Q24202879-9A29D709-BA52-4486-9AF5-672D0A8252FDQ24243916-BE41D602-1535-49A4-A2D4-DCE272139693Q26471106-00019D09-0039-4939-BC32-75A1DC51DFF4Q27004711-E72D0988-671C-4769-A1AC-3AFC313727FEQ33681237-AE35E54C-2DB7-4EDD-B164-CE837190CF0AQ33983611-42D3A8B6-27D9-4192-A7C3-B8DB49652E44Q38040734-D2F77FD7-2C8B-4252-9709-BAA47B12ABB1Q38663357-C58944DD-5162-49C5-9694-312DB34935CEQ42790860-DFE507AA-8EB2-4E6C-9821-54BB6DB6B550
P2860
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
type
label
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
prefLabel
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
P2093
P2860
P356
P1476
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
P2093
Christensson BA
Lindblad A
Ljungberg B
Malmborg AS
Nilsson-Ehle I
Strandvik B
P2860
P304
P356
10.1128/AAC.36.11.2512
P407
P577
1992-11-01T00:00:00Z